eXmoor Pharma

Bristol, UK
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
59.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (5)

Quick Facts: eXmoor Pharma

Signal Score
59.0/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Bristol, UK
Modalities
Cell Therapy, AAV
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesCell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 CGT manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Bristol, UK
Source: SEC EDGAR, press monitoring, company profiles
1 CGT manufacturing site
Recent Press5 articles
1 CGT manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100

Recent News 5 articles

general 2026-03-06
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer - Pharmafile
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer  Pharmafile
general 2026-03-06
New CCO strengthens global business strategy - European Biotechnology Magazine
New CCO strengthens global business strategy  European Biotechnology Magazine
general 2026-03-06
Mitigating Risk in Aging Lab Infrastructure - Lab Manager
Mitigating Risk in Aging Lab Infrastructure  Lab Manager
general 2026-03-04
Credibility, Culture, and Career Growth: Women Leaders on Thriving in Science - Lab Manager
Credibility, Culture, and Career Growth: Women Leaders on Thriving in Science  Lab Manager
general 2026-03-03
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer - Contract Pharma
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer  Contract Pharma
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs → AAV CDMOs →